Sara J. Buhrlage
Harvard University(US)Boston VA Research Institute(US)Dana-Farber Cancer Institute(US)Dana-Farber/Harvard Cancer Center(US)
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, Protein Degradation and Inhibitors, Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Peptidase Inhibition and Analysis
Most-Cited Works
- → Developing Irreversible Inhibitors of the Protein Kinase Cysteinome(2013)659 cited
- → Akkermansia muciniphila phospholipid induces homeostatic immune responses(2022)372 cited
- → Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development(2020)350 cited
- → A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemia(2013)344 cited
- → Screening of DUB activity and specificity by MALDI-TOF mass spectrometry(2014)336 cited
- → Deubiquitinases Maintain Protein Homeostasis and Survival of Cancer Cells upon Glutathione Depletion(2019)193 cited